IL326812A - חומרים טטראציקליים, תכשירים המכילים אותם ושימושיהם - Google Patents
חומרים טטראציקליים, תכשירים המכילים אותם ושימושיהםInfo
- Publication number
- IL326812A IL326812A IL326812A IL32681226A IL326812A IL 326812 A IL326812 A IL 326812A IL 326812 A IL326812 A IL 326812A IL 32681226 A IL32681226 A IL 32681226A IL 326812 A IL326812 A IL 326812A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- tetracyclic derivatives
- tetracyclic
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363534797P | 2023-08-25 | 2023-08-25 | |
| US202463627442P | 2024-01-31 | 2024-01-31 | |
| PCT/US2024/043554 WO2025049274A2 (en) | 2023-08-25 | 2024-08-23 | Tetracyclic derivatives, compositions and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326812A true IL326812A (he) | 2026-04-01 |
Family
ID=94820114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326812A IL326812A (he) | 2023-08-25 | 2024-08-23 | חומרים טטראציקליים, תכשירים המכילים אותם ושימושיהם |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2024334504A1 (he) |
| IL (1) | IL326812A (he) |
| TW (1) | TW202523668A (he) |
| WO (1) | WO2025049274A2 (he) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117677624A (zh) * | 2021-07-19 | 2024-03-08 | 上海艾力斯医药科技股份有限公司 | 新型吡啶并嘧啶衍生物 |
| WO2023001141A1 (en) * | 2021-07-23 | 2023-01-26 | Shanghai Zion Pharma Co. Limited | Kras g12d inhibitors and uses thereof |
| TW202315626A (zh) * | 2021-08-31 | 2023-04-16 | 大陸商勁方醫藥科技(上海)有限公司 | 嘧啶并環類化合物及其製法和用途 |
-
2024
- 2024-08-23 TW TW113131896A patent/TW202523668A/zh unknown
- 2024-08-23 WO PCT/US2024/043554 patent/WO2025049274A2/en active Pending
- 2024-08-23 AU AU2024334504A patent/AU2024334504A1/en active Pending
- 2024-08-23 IL IL326812A patent/IL326812A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202523668A (zh) | 2025-06-16 |
| WO2025049274A2 (en) | 2025-03-06 |
| WO2025049274A3 (en) | 2025-05-08 |
| AU2024334504A1 (en) | 2026-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL326812A (he) | חומרים טטראציקליים, תכשירים המכילים אותם ושימושיהם | |
| IL317671A (he) | תולדות אנילינו-פיראזול, תכשירים ושיטות שלהן | |
| EP4032892A4 (en) | CAMPTOTHECIN DERIVATIVE AND CONJUGATE THEREOF | |
| HUE065484T2 (hu) | Camptothecin-származékok | |
| EP4329879A4 (en) | N,N-DIMETHYLTRYPTAMINE COMPOSITIONS AND METHODS | |
| IL292668B1 (he) | נגזרת טריציקלית של דיהידרואימידזופירימידון, שיטת הכנה שלה, תכשיר רוקחות והשימוש בו | |
| PL3833343T3 (pl) | Heterocykliczne pochodne flawonu, kompozycje, i sposoby z nimi związane | |
| EP4534533A4 (en) | Azaquinolinone derivative, preparation method therefor and use thereof | |
| EP4007765A4 (en) | HUMAN SQUALAMIN DERIVATIVES, COMPOSITIONS CONTAINING THEM, AND METHODS OF USE THEREOF | |
| EP4247376A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| GB202304235D0 (en) | Compositions, methods and uses | |
| EP4370110A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| IL315948A (he) | תרכובות, תכשירים ושיטות | |
| EP4013421A4 (en) | TETRACYCLIC COMPOUNDS AND THEIR SALTS, COMPOSITIONS AND METHODS OF USE | |
| GB2626637B (en) | Compositions, methods and uses | |
| GB202401977D0 (en) | Compositions, methods and uses | |
| IL320161A (he) | תרכובות, הרכבים ושיטות | |
| GB202317463D0 (en) | Compositions, methods and uses | |
| GB202305630D0 (en) | Compositions, methods and uses | |
| CA3302588A1 (en) | Tetracyclic derivatives, compositions and methods thereof | |
| LT4010379T (lt) | Faktoriaus xa ir jo darinių kompozicijos ir gamybos būdai | |
| HK40123002A (en) | Anilino-pyrazole derivatives, compositions and methods thereof | |
| CA3262687A1 (en) | TRICYCLIC ARYL DERIVATIVES, AND ASSOCIATED COMPOSITIONS AND PROCESSES | |
| WO2010138670A3 (en) | Thiocolchicine derivatives, method of making and methods of use thereof | |
| GB202415328D0 (en) | Compositions, methods and uses |